Venous Disease Clinical Trial
— VELVETOfficial title:
Volume Estimation of Lower Limbs Before and After Endovascular Venous Intervention or Conventional Surgery in Venous Disease
Verified date | June 2024 |
Source | University Hospital, Angers |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic venous disease encompasses a broad spectrum of clinical presentations and is considered the most common vascular disease. Its causes are diverse, including primary defects of the wall or valves, chronic venous insufficiency, or lesions secondary to thrombosis, a post-thrombotic venous disease, affecting the superficial or deep venous network or both. The major symptom of venous disease is the enlargement of the lower limbs, which can result in edema. The evaluation of the volume of the lower limbs is very important in the diagnosis and follow-up of the venous pathology. There is a great variability of clinical pictures making it difficult to choose the therapeutic gesture. Endovascular venous interventions and conventional venous surgery are major advances in the treatment of venous disease. The variation of lower limb volume in pre and post procedure is a determining factor; thus orienting clinicians for post interventional therapeutic monitoring. Indeed the management of venous disease is multidisciplinary, it involves the cooperation of several specialists as part of its monitoring and its therapeutic management. Our collaborative group includes the Adult and Child Vascular Investigations Department, the Vascular Clinic, the Cardiovascular and Thoracic Surgery Department, and the Interventional Radiology Department. The evaluation of the variation of the volumes of the lower limbs is a capital data for the various specialists for the care in pre and post procedure. A volumetric 3D scanner system guarantees a reliable measurement ensuring optimal evolution and therapeutic follow-up.
Status | Completed |
Enrollment | 100 |
Est. completion date | March 30, 2022 |
Est. primary completion date | March 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - subjects referred for investigation of a preoperative venous assessment - affiliation to the French National healthcare system - french speaking patients Exclusion Criteria: - pregnancy - inability to understand the study goal - patients protected by decision of law |
Country | Name | City | State |
---|---|---|---|
France | UH Angers | Angers |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Angers |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Volume of lower limbs | Change of volume of the lower limbs will be assessed with a volumetric 3D scanner | 12 months | |
Secondary | Change in symptoms and quality of life | Change in symptoms and quality of life of patients assessed with the CIVIQ questionnaire | 12 months | |
Secondary | Change in symptoms and quality of life | Change in symptoms and quality of life of patients assessed with the SF36 questionnaire | 12 months | |
Secondary | Change in symptoms and quality of life | Change in symptoms and quality of life of patients assessed with the Villalta score for patients treated for post thrombotic syndrome | 12 months | |
Secondary | Change in symptoms and quality of life | Change in symptoms and quality of life of patients assessed with the CEAP classification for patients treated for superficial venous insufficiency | 12 months | |
Secondary | Validity | To validate the measurement of the volume of the lower limbs by a 3D scanner system compared to measurement by a tape measure (gold standard) in venous disease. | 1 hour |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05633277 -
Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
|
N/A | |
Completed |
NCT04758728 -
Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping
|
N/A | |
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Completed |
NCT06395025 -
Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group
|
N/A | |
Not yet recruiting |
NCT04358497 -
Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome
|
Phase 4 | |
Completed |
NCT01368159 -
Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein
|
Phase 4 | |
Recruiting |
NCT05628948 -
Vascular Lab Resource (VLR) Biorepository
|
||
Completed |
NCT06153680 -
Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return
|
N/A | |
Terminated |
NCT03363633 -
Perforator Vein Injection for Symptomatic Venous Disease
|
N/A | |
Recruiting |
NCT05489588 -
The GORE® VIAFORT Vascular Stent Iliofemoral Study
|
N/A | |
Not yet recruiting |
NCT06433024 -
Training of a Artificial Intelligence Model to Detect Venous Diseases Using PPG Technology
|
||
Completed |
NCT02655887 -
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
|
N/A | |
Recruiting |
NCT05050799 -
US Post-Market Surveillance Study of the Surfacer System
|
||
Completed |
NCT01993914 -
Prevalence of MTHFR Polymorphisms in Venous Disease
|
N/A | |
Active, not recruiting |
NCT04138134 -
Autophagy and Venous Endothelial Function
|
||
Terminated |
NCT04964817 -
HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study
|
||
Recruiting |
NCT02139085 -
Great Saphenous Vein Electrocoagulation
|
Phase 2 | |
Completed |
NCT01509599 -
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
|
Phase 1/Phase 2 | |
Terminated |
NCT03630185 -
A Comparison of Custom-manufactured vs. Off-the-rack (OTR) Compression Hosiery for Initial Management of Venous Disease
|
N/A |